Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Banu Arun

Showing results (21-30 of 179) with videos related to

Pageof 18
Sort By:
BMC Cancer|February 8, 2018
Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in JordanHikmat Abdel-Razeq, Amal Al-Omari, Farah Zahran, et al.
Psycho-Oncology|April 8, 2014
Ecological momentary assessment of sleep, symptoms, and mood during chemotherapy for breast cancerChelsea G Ratcliff, Cho Y Lam, Banu Arun, et al.
British Journal of Cancer|August 30, 2024
BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testingBanu Arun, Fergus J Couch, Jean Abraham, et al.
Breast Cancer Research and Treatment|March 26, 2018
Validation of a personalized risk prediction model for contralateral breast cancerMarzana Chowdhury, David Euhus, Banu Arun, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Protein-Folding Chaperones Predict Structure-Function Relationships and Cancer Risk in <i>BRCA1</i> Mutation CarriersBrant Gracia, Patricia Montes, Angelica Maria Gutierrez, et al.
Cell Reports|February 18, 2024
Protein-folding chaperones predict structure-function relationships and cancer risk in BRCA1 mutation carriersBrant Gracia, Patricia Montes, Angelica Maria Gutierrez, et al.
Journal of Genetic Counseling|October 22, 2020
Perceptions of provider's epistemic authority in response to variant of uncertain significance-related recommendationsSukh Makhnoon, Maureen Mork, Banu Arun, et al.
Journal of Cancer|July 9, 2013
Establishing a program for individuals at high risk for breast cancerFernando Cadiz, Henry M Kuerer, Julio Puga, et al.
Breast Cancer Research and Treatment|July 29, 2016
Erratum to: Rates of BRCA1/2 mutation testing among young survivors of breast cancerKenneth L Kehl, Chan Shen, Jennifer K Litton, et al.
International Journal of Oncology|May 16, 2015
The PARP inhibitor AZD2281 (Olaparib) induces autophagy/mitophagy in BRCA1 and BRCA2 mutant breast cancer cellsBanu Arun, Ugur Akar, Angelica M Gutierrez-Barrera, et al.
Pageof 18

Showing results (21-30 of 179) with videos related to

Sort By:
Pageof 18
BMC Cancer|February 8, 2018
Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in JordanHikmat Abdel-Razeq, Amal Al-Omari, Farah Zahran, et al.
Psycho-Oncology|April 8, 2014
Ecological momentary assessment of sleep, symptoms, and mood during chemotherapy for breast cancerChelsea G Ratcliff, Cho Y Lam, Banu Arun, et al.
British Journal of Cancer|August 30, 2024
BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testingBanu Arun, Fergus J Couch, Jean Abraham, et al.
Breast Cancer Research and Treatment|March 26, 2018
Validation of a personalized risk prediction model for contralateral breast cancerMarzana Chowdhury, David Euhus, Banu Arun, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Protein-Folding Chaperones Predict Structure-Function Relationships and Cancer Risk in <i>BRCA1</i> Mutation CarriersBrant Gracia, Patricia Montes, Angelica Maria Gutierrez, et al.
Cell Reports|February 18, 2024
Protein-folding chaperones predict structure-function relationships and cancer risk in BRCA1 mutation carriersBrant Gracia, Patricia Montes, Angelica Maria Gutierrez, et al.
Journal of Genetic Counseling|October 22, 2020
Perceptions of provider's epistemic authority in response to variant of uncertain significance-related recommendationsSukh Makhnoon, Maureen Mork, Banu Arun, et al.
Journal of Cancer|July 9, 2013
Establishing a program for individuals at high risk for breast cancerFernando Cadiz, Henry M Kuerer, Julio Puga, et al.
Breast Cancer Research and Treatment|July 29, 2016
Erratum to: Rates of BRCA1/2 mutation testing among young survivors of breast cancerKenneth L Kehl, Chan Shen, Jennifer K Litton, et al.
International Journal of Oncology|May 16, 2015
The PARP inhibitor AZD2281 (Olaparib) induces autophagy/mitophagy in BRCA1 and BRCA2 mutant breast cancer cellsBanu Arun, Ugur Akar, Angelica M Gutierrez-Barrera, et al.
Pageof 18